A detailed history of Oliver Luxxe Assets LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Oliver Luxxe Assets LLC holds 61,452 shares of MRK stock, worth $6.11 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares
61,452
Previous 61,053 0.65%
Holding current value
$6.11 Million
Previous $7.56 Million 7.67%
% of portfolio
1.32%
Previous 1.65%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$111.15 - $128.97 $44,348 - $51,459
399 Added 0.65%
61,452 $6.98 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $72,670 - $78,047
-587 Reduced 0.95%
61,053 $7.56 Million
Q1 2024

Apr 18, 2024

SELL
$113.24 - $131.95 $98,632 - $114,928
-871 Reduced 1.39%
61,640 $8.13 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $37,767 - $41,100
377 Added 0.61%
62,511 $6.81 Million
Q3 2023

Nov 09, 2023

BUY
$102.95 - $114.33 $112,833 - $125,305
1,096 Added 1.8%
62,134 $6.4 Million
Q2 2023

Aug 01, 2023

SELL
$108.61 - $118.38 $80,480 - $87,719
-741 Reduced 1.2%
61,038 $7.04 Million
Q1 2023

Apr 19, 2023

BUY
$102.94 - $114.86 $31,087 - $34,687
302 Added 0.49%
61,779 $6.57 Million
Q4 2022

Jan 30, 2023

BUY
$87.44 - $112.11 $8,131 - $10,426
93 Added 0.15%
61,477 $6.82 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $90,278 - $101,417
1,068 Added 1.77%
61,384 $5.29 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $5.04 Million - $5.71 Million
60,316 New
60,316 $5.5 Million
Q2 2021

Jul 29, 2021

SELL
$70.31 - $77.77 $2.7 Million - $2.99 Million
-38,434 Closed
0 $0
Q1 2021

Apr 29, 2021

SELL
$68.86 - $81.11 $695,141 - $818,805
-10,095 Reduced 20.8%
38,434 $2.96 Million
Q4 2020

Feb 04, 2021

SELL
$71.77 - $79.65 $5,382 - $5,973
-75 Reduced 0.15%
48,529 $4.13 Million
Q3 2020

Oct 20, 2020

BUY
$73.18 - $82.95 $64,032 - $72,581
875 Added 1.83%
48,604 $4.03 Million
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $610,118 - $694,246
-8,664 Reduced 15.36%
47,729 $3.69 Million
Q1 2020

Apr 21, 2020

BUY
$63.36 - $87.82 $257,178 - $356,461
4,059 Added 7.76%
56,393 $4.6 Million
Q4 2019

Feb 04, 2020

SELL
$77.58 - $87.54 $166,797 - $188,211
-2,150 Reduced 3.95%
52,334 $4.76 Million
Q3 2019

Oct 15, 2019

BUY
$76.08 - $82.93 $822,196 - $896,224
10,807 Added 24.74%
54,484 $4.51 Million
Q2 2019

Jul 10, 2019

BUY
$69.84 - $81.59 $8,799 - $10,280
126 Added 0.29%
43,677 $3.67 Million
Q1 2019

May 01, 2019

SELL
$69.58 - $79.36 $151,266 - $172,528
-2,174 Reduced 4.75%
43,551 $3.62 Million
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $160,620 - $186,398
-2,462 Reduced 5.11%
45,725 $3.49 Million
Q3 2018

Oct 10, 2018

BUY
$57.69 - $67.84 $2.78 Million - $3.27 Million
48,187 New
48,187 $3.42 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Oliver Luxxe Assets LLC Portfolio

Follow Oliver Luxxe Assets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.